Biography

Charles Gore is the Executive Director of the Medicines Patent Pool (MPP). He took up the post in July 2018 to guide MPP in its expansion from communicable diseases to all health areas covered by the WHO Essential Medicines List. He led MPP’s response to COVID-19, including the creation of the WHO/MPP mRNA Technology Transfer.

He was diagnosed with hepatitis C in 1995 and cirrhosis in 1998. In 2000 he established The Hepatitis C Trust in the UK which he ran for 18 years. In 2002 he was treated and cured of the virus. He was the European Liver Patients Association’s first President from 2004 to 2006. In 2007 he organised a meeting of hepatitis patient organisations from around the world. From this emerged the decision to hold an annual World Hepatitis Day and to create a new NGO, the World Hepatitis Alliance, of which Charles was President from 2007 until 2017. As a result of advocacy by the Alliance and its members, WHO adopted successive viral hepatitis resolutions in 2010, 2014 and 2016, making World Hepatitis Day an official day and creating the first Global Health Sector Strategy on viral hepatitis.

In 2024 Time Magazine named him as one of the 100 most influential people in health globally.